metacrine.comHealthcareFounded: 2014Funding to Date: $134.77MM
Metacrine is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal (GI) diseases.
View Enterprise Value for Metacrine.